Posts Tagged ‘Controversy’

‘Overdiagnosis’ in the Spotlight – Again

Posted on: October 14th, 2016 by admin 1 Comment

The New England Journal of Medicine (NEJM) yesterday published a paper entitled “Breast-cancer tumor size, overdiagnosis, and mammography screening effectiveness.” Lead author […]

The Tyranny of Open Access

Posted on: July 22nd, 2016 by admin 5 Comments

Yesterday I received an e-mail that read: “Dear Dr Vaughan, Hope this mail finds you in good health. We appreciate […]

Breast Cancer in Asia

Posted on: April 29th, 2016 by admin 3 Comments

Over the past two decades breast cancer has become a major health issue across the countries in the Pacific-Region where […]

An Illegitimate Dose Model?

Posted on: February 26th, 2016 by admin 3 Comments

In December 1946 the American scientist Hermann Muller was awarded the Nobel Prize in Medicine “for the discovery of the production of […]

The Rise of Consumer Advertising

Posted on: January 22nd, 2016 by admin 1 Comment

New Zealand and the United States are the only two countries in the world that permit the advertising of prescription […]

Screening Comes Under Scrutiny

Posted on: January 15th, 2016 by admin 1 Comment

Two important articles on cancer screening have been published this week, one in the British Medical Journal (BMJ) and another […]

The Forgotten Man of X-rays

Posted on: January 8th, 2016 by admin 1 Comment

Three Nobel Prizes have been awarded in medical imaging: for computed tomography (CT), magnetic resonance imaging (MRI), and X-rays. When […]

Should We Abandon Peer Review?

Posted on: September 11th, 2015 by admin 1 Comment

Dr Richard Smith (seen at right) is a physician who served as editor of the British Medical Journal (BMJ) between […]

The Origins of Peer Review

Posted on: September 4th, 2015 by admin

Scientists who publish their research are familiar with the process of peer review. But what are its origins? The Royal Society was […]

DCIS Rears its Head – Again

Posted on: August 28th, 2015 by admin 1 Comment

Ductal carcinoma in situ (DCIS) was the focus of a blog two years ago entitled “To treat or not to treat?” The […]